As a consequence of the transfer of its Jyseleca® business to Alfasigma, the revenues and costs related to Jyseleca® for the full years 2024 and 2023 are presented separately from the results of the ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...

Researchers at the Karlsruhe Institute of Technology (KIT) have synthesized a Bi5⁻ ring, a molecule with five bismuth atoms, ...

Combining concepts from statistical physics with machine learning, researchers at the University of Bayreuth have shown that ...

KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...